-
Mashup Score: 0The U.S. Food and Drug Administration Approves Epcoritamab-bysp (Epkinly) for Diffuse Large B-Cell Lymphoma - 12 month(s) ago
On May 19, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved epcoritamab-bysp (Epkinly, Genmab US, Inc.) for relapsed or
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Story of Hope - 1 year(s) ago
Everyone’s lymphoma story is unique and special. By simply sharing your story, you can impact countless lives.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#NationalCancerSurvivorsDay is coming up on June 4! As we get ready to celebrate our community of #lymphoma survivors, tell us what survivorship means to you by sharing a Story of Hope. Visit our collection of Stories of Hope and submit one of your own: https://t.co/wvpTbDnhP3 https://t.co/Pzdos023aE
-
-
Mashup Score: 2Support Services - 1 year(s) ago
The Lymphoma Research Foundation (LRF) offers a wide range of support services, for people with lymphoma and their loved ones.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
May is #MentalHealthAwarenessMonth. A lymphoma diagnosis can have serious impacts on your mental health. From the LRF Helpline to the Lymphoma Support Network, LRF offers helpful resources to help you navigate this difficult time. To learn more, visit: https://t.co/Ah3FdJLfbT https://t.co/ZNXQYJvY96
-
-
Mashup Score: 3Lindsay, Hodgkin Lymphoma - 1 year(s) ago
Lindsay, Hodgkin Lymphoma I was diagnosed with Hodgkin lymphoma in October 2003. Leading up to my diagnosis, I had been feeling absolutely awful. I was
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Just 2 years after being diagnosed with Hodgkin lymphoma, Lindsay ran her first marathon. In 2022, she completed the NYC Marathon with Team LRF to support lymphoma patients and survivors like herself. Read more about Lindsay's journey in her Story of Hope: https://t.co/vPJ5cqggQi https://t.co/7xxepdSk8p
-
-
Mashup Score: 5Lymphoma Research Foundation Funds 27 New Grants Supporting the Next Generation of Lymphoma Scientists - 1 year(s) ago
Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants New York, NY (May 1, 2023) – The Lymphoma Research Foundation
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
As #NationalCancerResearchMonth kicks off, LRF is pleased to announce our 2023 grantee class, which amounts to $5.4 million awarded to 27 LRF-funded grants that will advance our understanding of #lymphoma. To learn more about our 2023 grantee class, visit: https://t.co/8O1ahlxK6m https://t.co/uZiohXVdp2
-
-
Mashup Score: 1Washington DC Lymphoma Workshop: May 6, 2023 - 1 year(s) ago
The Lymphoma Workshop provides the latest information about lymphoma, current treatment options and support issues to members of the lymphoma community.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Don't miss out - our DC Lymphoma Workshop is just a week away! Learn the latest in #lymphoma at this free patient education program on May 6 chaired by Dr. Kieron Dunleavy (@MedStarGUH) and Dr. Nina Wagner-Johnston (@HopkinsMedicine). To learn more, visit: https://t.co/tcPO4RAiJL
-
-
Mashup Score: 0Lymphoma Walks - 1 year(s) ago
The Lymphoma Walk is a Team LRF hosted community fundraising event where survivors, caregivers, family, friends, and supporters join together to walk in honor and in memory of those whose lives have been touched by lymphoma.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Our 2023 walk season is kicking off! Find a Lymphoma Walk in your area to join a nationwide community of survivors, caregivers, family, friends, and supporters walking toward a common goal: eradicating lymphoma. To find a walk near you, visit: https://t.co/y7Ifg9vKBt https://t.co/mzsXrFCFEM
-
-
Mashup Score: 1The U.S. Food and Drug Administration Approves Polatuzumab Vedotin-piiq (Polivy) for Diffuse Large B-Cell Lymphoma - 1 year(s) ago
On April 19, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved polatuzumab vedotin-piiq (Polivy, Genentech, Inc.) with a
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
On April 19, 2023 the FDA announced it has approved polatuzumab vedotin-piiq (Polivy, Genentech, Inc.) for adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL). To learn more, visit us at: https://t.co/zKwzJBaKmk https://t.co/ikMokBdcRE
-
-
Mashup Score: 0Treatment Planning and Options - 1 year(s) ago
The first steps in participating in lymphoma treatment are to ask questions, learn about options, and work closely with the doctor.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Did you know Apr. 16 is #NationalHealthcareDecisionsDay? #NHDD exists to empower the public & providers on the importance of advance care planning. LRF offers resources to help you learn more about your #lymphoma diagnosis & understand your treatment plan: https://t.co/vvtIbLNBka https://t.co/5dY6XzeYCe
-
-
Mashup Score: 3In-Person Ask the Doctor About Lymphoma: Featuring Dr. Jennifer Amengual and Columbia University - April 20, 2023 - 1 year(s) ago
Ask the Doctor is a national series of two-hour, topic-specific, community-based programs that combine a presentation by a medical doctor.
Source: Lymphoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Our in-person Ask the Doctor About Lymphoma program is just a week away! Join us in NYC on April 20 to learn more about #lymphoma & get your questions answered at this free program feat. Dr. Jennifer Amengual (@ColumbiaMed). To learn more, visit: https://t.co/XEJzS2rjOr
-
On May 19, 2023, the FDA announced it has approved epcoritamab-bysp (Epkinly, Genmab US, Inc.) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. To learn more, visit: https://t.co/GH5sIcESQB https://t.co/1zBnieij2v